| Title |
|
Testosterone therapy considerations in estrogen, progesterone and androgen receptor positive breast cancer in a transgender male. |
|
|
| Publication Date |
|
| Author(s) |
|
| Type of document |
|
| OrcId |
|
#PLACEHOLDER_PARENT_METADATA_VALUE# |
|
|
#PLACEHOLDER_PARENT_METADATA_VALUE# |
|
|
#PLACEHOLDER_PARENT_METADATA_VALUE# |
|
|
#PLACEHOLDER_PARENT_METADATA_VALUE# |
|
|
| DOI |
|
| Abstract |
|
A 44-year-old premenopausal individual assigned female at birth but with a male gender identity, presented requesting masculinizing hormone therapy for long-standing gender dysphoria. His past medical history was unremarkable, and being adopted, his family history was unknown. Baseline blood tests and hormonal panel were within female reference ranges (Table). |
|
|
| Link |
|
| Citation |
|
Clinical Endocrinology 2020; 93(3): 355-357 |
|
|
| Jornal Title |
|
